ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Targeting Tex10 Overcomes Oxaliplatin Resistance by Competitively Disrupting the Non-Canonical BAF Complex in Colorectal Cancer.
Ping Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.